Top Purity >99% Main Estrogens CAS 50-27-1 Estriol in Treating Multiple Sclerosis

China Top Purity >99% Main Estrogens CAS 50-27-1 Estriol in Treating Multiple Sclerosis, Find details about China Estriol, CAS 50-27-1 from Top Purity >99% Main Estrogens CAS 50-27-1 Estriol in Treating Multiple Sclerosis

Trademark
oroni
Transport Package
Aluminum Bag; Drums or as Your Request
Specification
25kg/drum
Origin
China
HS Code
2915900090
Trademark
oroni
Transport Package
Aluminum Bag; Drums or as Your Request
Specification
25kg/drum
Origin
China
HS Code
2915900090
Top Purity >99% Main Estrogens CAS 50-27-1 Estriol in Treating Multiple Sclerosis

 

Product Description
Estriol
CAS No.: 50-27-1
Molecular Weight: 288.3814
Molecular Formula: C18H24O3
Appearance: White crystalline powder
Specification:USP
MOQ: 10g
Grade: Pharmaceutical Grade
Storage: Shading, confined preservation.
Description of Estriol :

1. Estriol can be a weak or strong estrogen depending on if it is given acutely or chronically when given to immature animals, but is an antagonist when given in combination with estradiol.

2. Estriol may play a role in the development of breast cancer, but based on in vitro research, does appear to act as an antagonist to the G-protein coupled estrogen receptor. Though estriol is used as part of the primarily North American phenomenon of bioidentical hormone replacement therapy, it is not approved for use by the FDA or Health Canada.Though initial research in the 1970s suggested it could be used therapeutically as an estrogen,subsequent research failed to confirm this hypothesis.In pregnant women with multiple sclerosis, estriol reduces the disease's symptoms noticeably, according to researchers at UCLA's Geffen Medical School.

3. Estriol can be a weak or strong estrogen depending on if it is given acutely or chronically when given to immature animals, but is an antagonist when given in combination with estradiol.

4. Estriol may play a role in the development of breast cancer, but based on in vitro research, does appear to act as an antagonist to the G-protein coupled estrogen receptor. Though estriol is used as part of the primarily North American phenomenon of bioidentical hormone replacement therapy, it is not
approved for use by the FDA or Health Canada.
 

COA :
 

ITEMSPECIFICATIONRESULT
CharacterWhite or almost white crystalline powderWhite crystalline powder
Specific rotation+54°to +62°+59.9°
Completeness of solutionClear and free from undissolved solidConforms
Identification(1) complies by IR
(2) complies by UV
Conforms
Conforms
Residue on IgnitionNot more than 0.1%0.05%
Loss on dryingNot more than 0.50.1%
Chromatographic
purity
Total impurities not more than 2.0%<2.0%
AssayIt should contain 97.0% to 102.0% of C18H24O3 calculated on dried basis98.4%
Particle sizeIt should be 90% below 30μmConforms
ConclusionConforms to USP36


Top Purity >99% Main Estrogens CAS 50-27-1 Estriol in Treating Multiple Sclerosis


Other SARMs

NameCAS NO.Usage
AICAR2627-69-2acts by entering nucleoside pools, significantly increasing levels of adenosine 
during periods of ATP breakdown
MK2866841205-47-8medical prescription for prevention of cachexia, atrophy, and sarcopenia and 
for Hormone or Testoserone Replacement Therapy.
MK-67715972-10-0 for the treatment of frailty in the elderly
LGD-40331165910-22-4pharmacological profile similar to that of enobosarm, Ostarine,MK-2866
GW1516317318-70-0For obesity, diabetes, dyslipidemia and cardiovascular disease
Andarine(S4)401900-40-0partial agonist, intended mainly for treatment of benign prostatic hypertrophy
SR90091379686-30-2under development at The Scripps Research Institute (TSRI), 
increases the level of metabolic activity in skeletal muscles of mice
RAD1401182367-47-0New generation for gaining mass and cutting edges
YK11431579-34-9YK11: a SARM and myostatin inhibitor in one
 
AC262356870888-46-3New SARMS
SR90111379686-29-9New SARMS
S231010396-29-8New SARMS
GW0724317318-84-6New SARMS


Top Purity >99% Main Estrogens CAS 50-27-1 Estriol in Treating Multiple Sclerosis
Top Purity >99% Main Estrogens CAS 50-27-1 Estriol in Treating Multiple Sclerosis
Top Purity >99% Main Estrogens CAS 50-27-1 Estriol in Treating Multiple Sclerosis
Top Purity >99% Main Estrogens CAS 50-27-1 Estriol in Treating Multiple Sclerosis
Our advantages: 
1. Top quality and factory price,a discount would be given when you make a large order.
2. Rich experienced in delivering,package will be reshipped if sent failed. 
3. Enough GW501516 Cardarine stock ensure the prompt delivery time. 
4. Good after-sales service,any of your question would be solved for the first as soon as possible.
5. Adhering to the principle of customer first conviction,we will provide the best and the most sincere services as possible as we can.